CN102680704A - 一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 - Google Patents
一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 Download PDFInfo
- Publication number
- CN102680704A CN102680704A CN2012101339004A CN201210133900A CN102680704A CN 102680704 A CN102680704 A CN 102680704A CN 2012101339004 A CN2012101339004 A CN 2012101339004A CN 201210133900 A CN201210133900 A CN 201210133900A CN 102680704 A CN102680704 A CN 102680704A
- Authority
- CN
- China
- Prior art keywords
- microalbumin
- test strips
- antibody
- preparation
- rabbit igg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 128
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 238000010166 immunofluorescence Methods 0.000 title claims abstract description 32
- NPRDEIDCAUHOJU-UHFFFAOYSA-N [Pt].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 Chemical class [Pt].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 NPRDEIDCAUHOJU-UHFFFAOYSA-N 0.000 claims description 68
- 238000001514 detection method Methods 0.000 claims description 66
- 238000000034 method Methods 0.000 claims description 37
- 239000012528 membrane Substances 0.000 claims description 29
- 238000011002 quantification Methods 0.000 claims description 27
- 238000004806 packaging method and process Methods 0.000 claims description 24
- 239000008363 phosphate buffer Substances 0.000 claims description 24
- 230000000274 adsorptive effect Effects 0.000 claims description 23
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 20
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 20
- 229940098773 bovine serum albumin Drugs 0.000 claims description 20
- 238000010790 dilution Methods 0.000 claims description 19
- 239000012895 dilution Substances 0.000 claims description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 18
- 239000004033 plastic Substances 0.000 claims description 18
- 229920003023 plastic Polymers 0.000 claims description 18
- 239000000020 Nitrocellulose Substances 0.000 claims description 17
- 229920001220 nitrocellulos Polymers 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 239000004094 surface-active agent Substances 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 238000013016 damping Methods 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 14
- 238000007789 sealing Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 239000007921 spray Substances 0.000 claims description 12
- 238000001291 vacuum drying Methods 0.000 claims description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 239000004793 Polystyrene Substances 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 9
- 229920002223 polystyrene Polymers 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- -1 polybutylene Polymers 0.000 claims description 8
- 229920000151 polyglycol Polymers 0.000 claims description 8
- 239000010695 polyglycol Substances 0.000 claims description 8
- 239000006166 lysate Substances 0.000 claims description 7
- 238000007639 printing Methods 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000005030 aluminium foil Substances 0.000 claims description 6
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- 229920000297 Rayon Polymers 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000002390 adhesive tape Substances 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000003365 glass fiber Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 229920001748 polybutylene Polymers 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 abstract description 14
- 238000004458 analytical method Methods 0.000 abstract description 6
- 230000002745 absorbent Effects 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 47
- 150000004032 porphyrins Chemical class 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 229910052697 platinum Inorganic materials 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000003317 immunochromatography Methods 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 238000010219 correlation analysis Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000013399 early diagnosis Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000007530 Essential hypertension Diseases 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- HCIIFBHDBOCSAF-UHFFFAOYSA-N octaethylporphyrin Chemical compound N1C(C=C2C(=C(CC)C(C=C3C(=C(CC)C(=C4)N3)CC)=N2)CC)=C(CC)C(CC)=C1C=C1C(CC)=C(CC)C4=N1 HCIIFBHDBOCSAF-UHFFFAOYSA-N 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- MHIITNFQDPFSES-UHFFFAOYSA-N 25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1(25),2,4,6,8(27),9,11,13,15,17,19,21,23-tridecaene Chemical compound N1C(C=C2C3=CC=CC=C3C(C=C3NC(=C4)C=C3)=N2)=CC=C1C=C1C=CC4=N1 MHIITNFQDPFSES-UHFFFAOYSA-N 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 206010066786 Diabetic keratopathy Diseases 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027525 Microalbuminuria Diseases 0.000 description 1
- 208000013901 Nephropathies and tubular disease Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000003370 dye binding method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 238000002284 excitation--emission spectrum Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012092 latex agglutination test Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002558 medical inspection Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000001455 metallic ions Chemical class 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YNHJECZULSZAQK-UHFFFAOYSA-N tetraphenylporphyrin Chemical compound C1=CC(C(=C2C=CC(N2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3N2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 YNHJECZULSZAQK-UHFFFAOYSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
重复检测序号 | 1 | 2 | 3 | 4 | 5 |
T/C | 36.70 | 35.40 | 37.80 | 36.85 | 38.10 |
MA浓度(ng/ml) | 30.0 | 29.5 | 31.0 | 30.0 | 31.5 |
重复检测序号 | 6 | 7 | 8 | 9 | 10 |
T/C | 35.45 | 38.20 | 37.60 | 34.75 | 34.80 |
MA浓度(ng/ml) | 29.5 | 31.5 | 31.0 | 29.0 | 29.0 |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210133900.4A CN102680704B (zh) | 2012-04-28 | 2012-04-28 | 一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210133900.4A CN102680704B (zh) | 2012-04-28 | 2012-04-28 | 一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102680704A true CN102680704A (zh) | 2012-09-19 |
CN102680704B CN102680704B (zh) | 2015-02-11 |
Family
ID=46812947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210133900.4A Active CN102680704B (zh) | 2012-04-28 | 2012-04-28 | 一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102680704B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102879586A (zh) * | 2012-10-11 | 2013-01-16 | 南京基蛋生物科技有限公司 | 微量白蛋白荧光免疫定量检测试剂盒及其制备方法 |
CN103217525A (zh) * | 2013-03-21 | 2013-07-24 | 上海执诚生物科技股份有限公司 | 一种含有提高胱抑素c胶乳包被抗体的稳定性的组合物、稳定剂及其制备方法和用途 |
CN104345150A (zh) * | 2013-07-26 | 2015-02-11 | 深圳市艾瑞生物科技有限公司 | 一种检测糖化白蛋白免疫层析试纸条及其制备方法 |
CN106872420A (zh) * | 2016-12-27 | 2017-06-20 | 厦门奥德生物科技有限公司 | 一种时间分辨荧光定量检测尿微量白蛋白的试剂盒及方法 |
CN107037025A (zh) * | 2017-06-24 | 2017-08-11 | 杭州微瑞科技有限公司 | 镧系高敏荧光层析装置及检测方法 |
CN110646616A (zh) * | 2019-09-05 | 2020-01-03 | 桂林理工大学 | 一种检测血清中人cTnI的超敏荧光猝灭免疫传感器及检测方法 |
CN112876562A (zh) * | 2019-11-30 | 2021-06-01 | 江苏众红生物工程创药研究院有限公司 | 抗人血清白蛋白抗体及其应用 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092424A (zh) * | 1992-10-30 | 1994-09-21 | 夸德拉逻辑技术股份有限公司 | 对特定波长光敏的卟菲花青和扩增的类卟啉化合物及其制备和使用方法 |
EP0978568A2 (en) * | 1998-08-03 | 2000-02-09 | Bayer Corporation | Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity |
US20050112703A1 (en) * | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
US20090111171A1 (en) * | 2003-02-13 | 2009-04-30 | Inverness Medical Switzerland Gmbh | Lateral flow immunoassay controls |
CN101710066A (zh) * | 2009-12-23 | 2010-05-19 | 重庆大学 | 检测有机磷农药残留量的方法及液态卟啉光学检测装置 |
CN101776601A (zh) * | 2010-01-25 | 2010-07-14 | 泸州老窖集团有限责任公司 | 一种快速检测农药残留的方法 |
CN102023211A (zh) * | 2010-11-19 | 2011-04-20 | 广州万孚生物技术有限公司 | 一种全程定量检测c反应蛋白的免疫层析试纸条及其制备方法 |
CN102087293A (zh) * | 2010-12-31 | 2011-06-08 | 广州万孚生物技术有限公司 | 一种全程定量检测肌钙蛋白i的免疫层析试纸条及其制备方法 |
CN102183647A (zh) * | 2011-01-24 | 2011-09-14 | 杭州师范大学 | 一种乙型肝炎病毒表面抗原的检测试剂及检测方法 |
CN202049158U (zh) * | 2010-12-09 | 2011-11-23 | 苏州生物医学工程技术研究所 | 一种免疫荧光试纸条 |
CN102393463A (zh) * | 2011-10-21 | 2012-03-28 | 广州万孚生物技术有限公司 | 荧光定量检测沙丁胺醇的试剂盒和荧光标记液的制备方法 |
-
2012
- 2012-04-28 CN CN201210133900.4A patent/CN102680704B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092424A (zh) * | 1992-10-30 | 1994-09-21 | 夸德拉逻辑技术股份有限公司 | 对特定波长光敏的卟菲花青和扩增的类卟啉化合物及其制备和使用方法 |
EP0978568A2 (en) * | 1998-08-03 | 2000-02-09 | Bayer Corporation | Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity |
US20090111171A1 (en) * | 2003-02-13 | 2009-04-30 | Inverness Medical Switzerland Gmbh | Lateral flow immunoassay controls |
US20050112703A1 (en) * | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
CN101710066A (zh) * | 2009-12-23 | 2010-05-19 | 重庆大学 | 检测有机磷农药残留量的方法及液态卟啉光学检测装置 |
CN101776601A (zh) * | 2010-01-25 | 2010-07-14 | 泸州老窖集团有限责任公司 | 一种快速检测农药残留的方法 |
CN102023211A (zh) * | 2010-11-19 | 2011-04-20 | 广州万孚生物技术有限公司 | 一种全程定量检测c反应蛋白的免疫层析试纸条及其制备方法 |
CN202049158U (zh) * | 2010-12-09 | 2011-11-23 | 苏州生物医学工程技术研究所 | 一种免疫荧光试纸条 |
CN102087293A (zh) * | 2010-12-31 | 2011-06-08 | 广州万孚生物技术有限公司 | 一种全程定量检测肌钙蛋白i的免疫层析试纸条及其制备方法 |
CN102183647A (zh) * | 2011-01-24 | 2011-09-14 | 杭州师范大学 | 一种乙型肝炎病毒表面抗原的检测试剂及检测方法 |
CN102393463A (zh) * | 2011-10-21 | 2012-03-28 | 广州万孚生物技术有限公司 | 荧光定量检测沙丁胺醇的试剂盒和荧光标记液的制备方法 |
Non-Patent Citations (1)
Title |
---|
李改茹等: "金属钯/铂卟啉室温磷光探针在生物医学领域的应用研究", 《分析化学评述与进展》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102879586A (zh) * | 2012-10-11 | 2013-01-16 | 南京基蛋生物科技有限公司 | 微量白蛋白荧光免疫定量检测试剂盒及其制备方法 |
CN103217525A (zh) * | 2013-03-21 | 2013-07-24 | 上海执诚生物科技股份有限公司 | 一种含有提高胱抑素c胶乳包被抗体的稳定性的组合物、稳定剂及其制备方法和用途 |
CN104345150A (zh) * | 2013-07-26 | 2015-02-11 | 深圳市艾瑞生物科技有限公司 | 一种检测糖化白蛋白免疫层析试纸条及其制备方法 |
CN106872420A (zh) * | 2016-12-27 | 2017-06-20 | 厦门奥德生物科技有限公司 | 一种时间分辨荧光定量检测尿微量白蛋白的试剂盒及方法 |
CN106872420B (zh) * | 2016-12-27 | 2019-12-17 | 厦门奥德生物科技有限公司 | 一种时间分辨荧光定量检测尿微量白蛋白的试剂盒及方法 |
CN107037025A (zh) * | 2017-06-24 | 2017-08-11 | 杭州微瑞科技有限公司 | 镧系高敏荧光层析装置及检测方法 |
CN110646616A (zh) * | 2019-09-05 | 2020-01-03 | 桂林理工大学 | 一种检测血清中人cTnI的超敏荧光猝灭免疫传感器及检测方法 |
CN112876562A (zh) * | 2019-11-30 | 2021-06-01 | 江苏众红生物工程创药研究院有限公司 | 抗人血清白蛋白抗体及其应用 |
CN112876562B (zh) * | 2019-11-30 | 2022-05-27 | 江苏众红生物工程创药研究院有限公司 | 抗人血清白蛋白抗体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102680704B (zh) | 2015-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102680702B (zh) | 一种快速定量检测c-反应蛋白的免疫荧光试纸条组件、及其制成的检测卡组件和制备方法 | |
CN102680704B (zh) | 一种快速定量检测微量白蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN108254562B (zh) | 检测myo的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 | |
CN102662055B (zh) | 一种快速定量检测肌钙蛋白i的免疫荧光试纸条组件、及其制成的检测卡组件和制备方法 | |
CN108254563B (zh) | 检测cTnI的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 | |
CN102539785B (zh) | 一种全程定量检测c-反应蛋白的荧光免疫层析方法及其试剂盒 | |
CN102662065B (zh) | 一种快速定量检测多种蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN108254550A (zh) | 检测ck-mb的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 | |
CN105403698A (zh) | 采用内部校正系统的诊断性试验试剂盒 | |
CN102680703B (zh) | 一种快速定量检测肌红蛋白的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN102680692A (zh) | 基于近红外荧光标记物的免疫层析定量检测试剂 | |
CN102866251A (zh) | 基于磷光发光技术的免疫荧光试纸条及其制备方法和应用 | |
WO2018068582A1 (zh) | 一种免疫层析检测装置 | |
CN109521207A (zh) | 一种igf-1荧光免疫层析检测试剂盒 | |
CN102707056A (zh) | 快速定量检测心肌肌酸激酶同工酶的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
CN204964521U (zh) | 一种crp/saa定量联合检测免疫荧光层析试纸 | |
CN104849264B (zh) | 一种化学发光免疫试条及其制备方法 | |
CN205484371U (zh) | 一种肿瘤标志物检测试剂盒 | |
CN104569431A (zh) | 一种快速定量检测肌钙蛋白i的均相荧光免疫试剂组及其制备方法 | |
CN104569374B (zh) | 一种快速定量检测c‑反应蛋白的均相荧光免疫试剂组及其制备方法 | |
CN106645043A (zh) | 快速定量检测小分子化合物的试剂盒和方法 | |
JPH09113511A (ja) | グリコアルブミン測定用乾式試験片 | |
CN103293300A (zh) | 基于磷光发光技术的时间分辨荧光检测试剂盒及其制备方法和应用 | |
CN102692508B (zh) | 一种快速定量检测肌钙蛋白t的免疫荧光试纸条组件及其制成的检测卡组件和制备方法 | |
JP3385377B2 (ja) | 免疫測定具 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: immunofluorescence test strip module for rapidly and quantitatively testing microalbumin, test card module made of same and preparation method thereof Effective date of registration: 20190304 Granted publication date: 20150211 Pledgee: Guangzhou Branch of Guangzhou Bank Co.,Ltd. Pledgor: GUANGZHOU HONGQI OPTICAL INSTRUMENT TECHNOLOGY Co.,Ltd. Registration number: 2019440000084 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20190729 Granted publication date: 20150211 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20220729 Granted publication date: 20150211 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20220729 Granted publication date: 20150211 |